Gilead sciences stock price.

According to the issued ratings of 16 analysts in the last year, the consensus rating for Gilead Sciences stock is Hold based on the current 1 sell rating, 10 hold ratings and 5 buy ratings for GILD. The average twelve-month price prediction for Gilead Sciences is $88.22 with a high price target of $105.00 and a low price target of $71.00 ...Sep-07-23 08:55PM. Gilead Prices $2 Billion of Senior Unsecured Notes. (Business Wire) 06:00PM. Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know. (Zacks) Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need.Gilead Sciences, Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: GILD | NasdaqGilead Sciences Inc. research and ratings by Barron's. View GILD revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $116.00: Low: $71. ...

Gilead Sciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. GILD updated stock price target summary.

Right now, Gilead Sciences has a very attractive dividend yield of 4.7%. Right now, the company is paying a quarterly dividend of $0.73 and since Gilead Sciences started paying a dividend in 2015 ...

To opt-in for investor email alerts, please: Enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. Given the large stake in the stock by institutions, Gilead Sciences' stock price might be vulnerable to their trading decisions. 51% of the business is held by the top 18 shareholders.Gilead Sciences, Inc. (/ ... citing a market capitalization of US$113 billion and stock appreciation of 100%, ... and argued in its 2015 report that Gilead set prices high in disregard of the human cost and in order to set the stage for a higher eventual price for Sovaldi's successor, Harvoni.The Zacks Consensus Estimate for Alkermes’ 2023 earnings has increased from 29 cents to $1.27 in the past 60 days. Earnings estimates for 2024 have increased from $1.73 to $2.08 in the past 60 ...Feb 6, 2023 · Shares of Gilead Sciences (GILD 1.30%) marched higher on Thursday, Feb. 2 in response to a fourth-quarter earnings report that exceeded expectations. A day later, the U.S. Food and Drug ...

Gilead Sciences Inc. experienced a significant surge in its stock price on Wednesday, climbing 1.35% to reach $75.70. This rise came during a generally favorable trading session for the stock market, with the S&P 500 Index gaining 0.41% to close at 4,556.62, and the Dow Jones Industrial Average rising 0.53% to 35,273.03.

Gilead Sciences Stock: Bear vs. Bull. 488%. Motley Fool Returns. Market-beating stocks from our award-winning analyst team. Stock Advisor Returns. ... Stock Advisor list price is $199 per year.

Gilead Sciences Inc. research and ratings by Barron's. View GILD revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $116.00: Low: $71. ... Investor Relations. At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.A cheap buy with great potential. Shares of Gilead are up around 5% this year, tracking closely with the S&P 500. According to analyst projections, Gilead's stock is trading at a forward price-to ...Gilead Sciences stock forecast Twenty-two analysts forecast the average price in 12 months at $79.06 with a high forecast of $105.00 and a low forecast of $67.00.Gilead Sciences, Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: GILD | NasdaqGilead sciences discounted cash flow analysis (my table and assumptions) ... My final price target for Gilead stock in 2023 is therefore the average of DCF / EBITDA multiple, which is $112 per ...The Gilead stock price gained 1.37% on the last trading day (Friday, 1st Dec 2023), ... (+/-1.79%) up or down from last closing price. If Gilead Sciences takes out the full calculated possible swing range there will be an estimated 3.58% move between the lowest and the highest trading price during the day. ...

Shares of Gilead Sciences (GILD 1.30%) marched higher on Thursday, Feb. 2 in response to a fourth-quarter earnings report that exceeded expectations. A day later, the U.S. Food and Drug ...77.89. 76.40. 4,877,200. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for GILD stock on Yahoo Finance. View daily, weekly or monthly formats back to when Gilead Sciences, Inc. stock was issued.Pharma stock Gilead Sciences is well-positioned for the next few years with a growing core business, a healthy pipeline, and cash flow to sustain capital return. GILD : 77.65 …Investor Relations. At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.Gilead Sciences Inc stock price (GILD) NASDAQ: GILD. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert …

Gilead Sciences, Inc. Common Stock (GILD) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.

The average price target of $90.50 for Gilead Sciences Inc's stock set by fiveteen distinguished analysts in recent weeks would represent a potential upside of approximately 16.55% from the last closing price in December, 2023 if reached by the end of the year.Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.The share price of Gilead Sciences, Inc. (GILD) now. What analysts predict: $89.76. 52-week High/Low: $86.75 / $72.54. 50/200 Day Moving Average: $76.82 / $78.83. This figure corresponds to the Average Price over the previous 50/200 days. For Gilead Sciences stocks, the 50-day moving average is the resistance level today. For Gilead Sciences ...Gilead sciences discounted cash flow analysis (my table and assumptions) ... My final price target for Gilead stock in 2023 is therefore the average of DCF / EBITDA multiple, which is $112 per ...Sociology, which is the study of human social behavior, can have a quantifiable effect on the application of economics in many ways. Stock market prices, for example, are often influenced much more by the perceptions of investors and shareh...Interactive Chart for Gilead Sciences, Inc. (GILD), analyze all the data with a huge range of indicators. Home; Mail; ... NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W ...

NASDAQ Composite Index, S&P 500, NASDAQ 100, S&P 400 MidCap, S&P 100, BX Swiss - USA. GILEAD SCIENCES AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Gilead Sciences Inc. | 885823 | GILD ...

Gilead Sciences, Inc. (GILD) stock forecast and price target. Find the latest Gilead Sciences, Inc. GILD analyst stock forecast, price target, and recommendation trends with in-depth analysis from ...

The stock price currently stands at $76.36, while its GF Value, an estimate of fair value, is $72.82. This comparison suggests that Gilead Sciences might be fairly valued. Here is the income ...Investor Relations. At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.To opt-in for investor email alerts, please: Enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.GILEAD SCIENCES INC. GILEAD SCIENCES INC 0QYQ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits and dividends. The latest closing stock price for Gilead Sciences as of December 01, 2023 is 77.65.. The all-time high Gilead Sciences stock closing price was 91.98 on June 23, 2015.; The Gilead Sciences 52-week high stock price is 89.74, which is 15.6% …Gilead Sciences (GILD Quick Quote GILD - Free Report) ... This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it ...Gilead Sciences | GILD. Stock Price | Live Quote | Historical Chart. Gilead Sciences traded at $74.92 this Monday November 27th, decreasing $0.46 or 0.61 percent since …Options Prices. Barchart allows you to view options by Expiration Date (select the expiration month/year using the drop-down menu at the top of the page). Weekly expiration dates are labeled with a (w) in the expiration date list. Options information is delayed 15 minutes. Select an options expiration date from the drop-down list at the top of ...Nov 28, 2023 · The current dividend yield for Gilead Sciences is 3.86%. Learn more on GILD's dividend yield history. How much is Gilead Sciences's annual dividend? The annual dividend for GILD shares is $3.00. As a leader in various therapeutic areas, Gilead Sciences' total revenue was $7,042 million in Q3 2022, up 12.5% QoQ. Read why I rate GILD stock a Sell.Gilead Sciences is still deeply undervalued, which should lead to higher stock prices in the coming quarters. But maybe a catalyst is necessary to driver the stock price higher.

Stock split history for Gilead Sciences since 1992. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.Nov 30, 2023 · According to the issued ratings of 16 analysts in the last year, the consensus rating for Gilead Sciences stock is Hold based on the current 1 sell rating, 10 hold ratings and 5 buy ratings for GILD. The average twelve-month price prediction for Gilead Sciences is $88.22 with a high price target of $105.00 and a low price target of $71.00 ... Gilead Sciences Inc (NASDAQ:GILD) Gilead Sciences Inc. 77.65. Delayed Data. As of Dec 01. +1.05 / +1.37%. Today’s Change. 72.87. Today ||| 52-Week Range.Instagram:https://instagram. what is the best forex broker in usablackstone bcredtotal oil stockmeta stock prediction GILD, Gilead Sciences - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines publicly traded copper companiesprice 1964 kennedy half dollar Gilead Sciences Inc. 333 Lakeside Drive. Foster City, California 94404. Phone 1 650 574-3000. Industry Biotechnology. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023.Gilead Sciences Inc. research and ratings by Barron's. View GILD revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $116.00: Low: $71. ... lipper fund flows The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by picking above-average stocks. For example, the Gilead Sciences, Inc. ( NASDAQ ...Valuations in the stock market are sky-high, but it's possible to find companies that are reasonably priced. Biotech giant Gilead Sciences (GILD 1.05%) is a good example. It is trading at a mere 8 ...Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. ... Price/Sales: 4.00: Price/Book: 4.56: Competitors----AMGN Amgen +2.76 +1.02%: BIIB ...